SCHEMBL3769159

SCHEMBL3769159

Cc1ccc2c(c1)C(CC(=O)O)N(c1ccccc1)S2(=O)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTDSP1 Q9GZU7 2/20 0.56
MAPT P10636 2/20 0.51
ATM Q13315 1/20 0.51
APOBEC3A P31941 1/20 0.47
DUSP3 P51452 1/20 0.47
PTPN5 P54829 1/20 0.47
PTPN11 Q06124 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
PTGDR2 Q9Y5Y4 6/20 0.44
PTPN7 P35236 1/20 0.37
HTT P42858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3761875 0.90 CTDSP1 (0.55) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3766960 0.88 CTDSP1 (0.53) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3759792 0.88 CTDSP1 (0.45) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3762673 0.87 MAPT (0.60) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3770547 0.86 MAPT (0.56) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3764408 0.85 MAPT (0.68) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3769238 0.85 CTDSP1 (0.56) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL8169205 0.85 CTDSP1 (0.53) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3759651 0.85 MAPT (0.54) CTDSP1MAPTATMAPOBEC3ADUSP3
SCHEMBL3764452 0.84 CTDSP1 (0.70) CTDSP1MAPTATMAPOBEC3ADUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
WO-2008142376-A1 BICYCLOSULFONYL ACID (BCSA) COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS INHIBOX LTD. (GB) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents TNF, CS, COASY CTDSP1 725/4885MAPT 2661/4885ATM 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.